nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Beyond the Evidence of the New Hypertension Guidelines. Blood pressure measurement – is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I)
|
Pater, Cornel |
|
2005 |
6 |
1 |
|
artikel |
2 |
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors
|
Espeland, Mark A |
|
2005 |
6 |
1 |
|
artikel |
3 |
Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate
|
Dietz, Ulrich |
|
2005 |
6 |
1 |
|
artikel |
4 |
Compliance of a cobalt chromium coronary stent alloy – the COVIS trial
|
Hagemeister, Jens |
|
2005 |
6 |
1 |
|
artikel |
5 |
Coronary artery bypass surgery in high-risk patients
|
Kunt, Alper Sami |
|
2005 |
6 |
1 |
|
artikel |
6 |
Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy? – A systematic review
|
Scharplatz, Madlaina |
|
2005 |
6 |
1 |
|
artikel |
7 |
Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients – the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]
|
Penne, E Lars |
|
2005 |
6 |
1 |
|
artikel |
8 |
Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study
|
Fellström, Bengt |
|
2005 |
6 |
1 |
|
artikel |
9 |
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction
|
Turer, Aslan T |
|
2005 |
6 |
1 |
|
artikel |
10 |
Exercise training improves aerobic endurance and musculoskeletal fitness in female cardiac transplant recipients
|
Haykowsky, Mark |
|
2005 |
6 |
1 |
|
artikel |
11 |
Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]
|
Ostadal, Petr |
|
2005 |
6 |
1 |
|
artikel |
12 |
Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities
|
Pater, Cornel |
|
2005 |
6 |
1 |
|
artikel |
13 |
Predictors of post-operative mortality following treatment for non-ruptured abdominal aortic aneurysm
|
Urbonavicius, Sigitas |
|
2005 |
6 |
1 |
|
artikel |
14 |
Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma
|
Tengiz, Istemihan |
|
2005 |
6 |
1 |
|
artikel |
15 |
Symptomatic relief precedes improvement of myocardial blood flow in patients under spinal cord stimulation
|
Diedrichs, Holger |
|
2005 |
6 |
1 |
|
artikel |
16 |
The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II)
|
Pater, Cornel |
|
2005 |
6 |
1 |
|
artikel |
17 |
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
|
Kulik, Alexander |
|
2005 |
6 |
1 |
|
artikel |
18 |
The SPHERE Study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses. [ISRCTN24081411]
|
Murphy, Andrew W |
|
2005 |
6 |
1 |
|
artikel |